Some patients receive anti-androgen therapies may develop a deadly treatment-resistant prostate cancer subtype called neuroendocrine (NEPC).
The cancer cells are completely reprogram themselves . Similar to a cold virus mutating to become resistance to a particular drug. The tumor even loses the receptor that is targeted by current treatments.
These targeted therapies are the cause of the PC becomes more aggressive and deadly.
This article describes the transformation of PC to NEPC type, also the treatment to prevent this transformation.
sciencedaily.com/releases/2...
Bob